(Q45410795)

English

Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep

scientific article published on 5 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Recombinant canarypox virus vaccine co-expressing genes encoding the VP2 and VP5 outer capsid proteins of bluetongue virus induces high level protection in sheep (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

bluetongue virus

0 references

1 reference

based on heuristic

inferred from title

Canarypox virus

object named as

canarypox virus

1 reference

based on heuristic

inferred from title

Federica Monaco

8

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Giovanni Savini

9

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

author name string

Josh D Boone

1

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Udeni B Balasuriya

2

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Kemal Karaca

3

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jean-Christophe Audonnet

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Jiansheng Yao

5

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Ling He

6

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Robert Nordgren

7

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Ian A Gardner

10

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

N James Maclachlan

11

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

language of work or name

0 references

publication date

5 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

672-678

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

The epidemiology of bluetongue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Climate change and the recent emergence of bluetongue in Europe

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Assignment of the genome segments of bluetongue virus type 1 to the proteins which they encode.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Changes in the outer capsid proteins of bluetongue virus serotype ten that abrogate neutralization by monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Isolation of a capsid protein of bluetongue virus that induces a protective immune response in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Antibody responses and protective immunity to recombinant vaccinia virus-expressed bluetongue virus antigens.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Protective efficacy of virus-like particles for bluetongue disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

The effects of vaccination of Merino ewes with an attenuated Australian bluetongue virus serotype 23 at different stages of gestation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Active circulation of bluetongue vaccine virus serotype-2 among unvaccinated cattle in central Italy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Live attenuated bluetongue vaccine viruses in Dorset Poll sheep, before and after passage in vector midges (Diptera: Ceratopogonidae).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Duration of viraemia infectious to Culicoides sonorensis in bluetongue virus-infected cattle and sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

The role of endothelial cell-derived inflammatory and vasoactive mediators in the pathogenesis of bluetongue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Occurrence of genetic drift and founder effect during quasispecies evolution of the VP2 and NS3/NS3A genes of bluetongue virus upon passage between sheep, cattle, and Culicoides sonorensis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Sequence comparison of the L2 and S10 genes of bluetongue viruses from the United States and the People's Republic of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Vaccinia virus as an expression vector

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Comparison of virologic and serologic responses of lambs and calves infected with bluetongue virus serotype 10.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Equine West Nile Encephalitis, United States

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Vaccines for bluetongue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

VP2-segment sequence analysis of some isolates of bluetongue virus recovered in the Mediterranean basin during the 1998-2003 outbreak

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Differentiation between field and vaccine strain of bluetongue virus serotype 16.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Efficacy of a recombinant equine influenza vaccine against challenge with an American lineage H3N8 influenza virus responsible for the 2003 outbreak in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Efficacy of a canarypox virus-vectored vaccine against feline leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

Recombinant virus vaccine for bluetongue disease in sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.08.025

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.08.025

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

release_lz7emmxcpnbkvogyjbecvlvs6m

1 reference

https://api.fatcat.wiki/v0/release/lz7emmxcpnbkvogyjbecvlvs6m

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45410795&oldid=2076835158"